Let’s explore “Hashimoto’s”

Dan and Jackson discuss the Algevity ingredient, Nrf2, antioxidant research, and VARS Catalase, including an update on the study’s publication status.

Dr. Purser’s subscriber report on MAO-A, genetic terminology, and the anxiety-related questions discussed in the public introduction.

This report overview covers eotaxin-1, CCR3, eosinophils, allergy, and the report’s discussion of respiratory and neurological conditions.

This report overview covers RANTES, CCR5, T cells, monocytes, eosinophils, and the report’s discussion of inflammatory conditions.

This report overview covers membrane and soluble CD14, lipopolysaccharide (LPS), TLR4, and the report’s discussion of innate immune activation.

This report overview covers CD40L, antigen-presenting cells, antibody class switching, and the report’s discussion of autoimmunity.

This report overview covers CXCL13, B-cell and follicular helper T-cell movement, germinal centers, and the report’s discussion of immune-cell organization.

This report overview covers the source’s brief labels for cytokines, chemokines, receptors, and related genes on the comprehensive panel, including CD40LG, IL18R1, DDAH1, RAD50, and SLC19A1.

This report overview covers the author’s homocysteine teaching notes on transsulfuration, methylation, glutathione, genetic variants, cytokines, and the connections proposed in the collection.

This report overview covers the IFNG promoter variant rs2069705, the -1616 position, STAT4, and the report’s interpretation of interferon-gamma regulation.

This report overview covers the IFNG variant rs2430561, the +874 T/A position, NF-kappa B, and the report’s discussion of interferon-gamma regulation.

This report overview covers interleukin-10, rs1800896, rs1800871, rs1800872, regulatory T cells, and the report’s discussion of inflammatory regulation.